Inhibitors of poly‐ADP ribose polymerase (PARP), which aids break repair, are successful against cancer by trapping PARP on damage and blocking repair182 and inhibitors of the glycohydrolase that removes poly‐ADP ribose and releases PARP1 are under active preclinical cancer investigation.9 The gene discussed is PARP1; the disease is cancer.